USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Paris-based asset manager Kurma Partners has raised 140 million euros ($154 million), successfully completing the first closing of Biofund IV 4 October 2024
Caliway Biopharmaceuticals has successfully completed its initial public offering, raising NT$6.4 billion ($206 million), the largest IPO in Taiwan's biotech industry to date. 3 October 2024
Shares of UK drug developer Hemogenyx Pharmaceuticals rose as much as 9% and closed up 5.9% at 1.70 pence yesterday on the news of a further investment from Prevail Partners. 3 October 2024
UK-based biotech Resolution Therapeutics has announced the completion of a £63.5 million ($76.8 million) series B financing round led by Syncona. 3 October 2024
UK-based biotech LoQus23 Therapeutics has closed a £35 million ($43 million) series A financing round, led by Forbion, with support from SV Health Investors' Dementia Discovery Fund and Novartis Venture Fund. 2 October 2024
USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Boston, USA-based biotech Aktis Oncology, which is targeting alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced the successful closing of an oversubscribed and upsized $175 million Series B financing. 1 October 2024
Chicago, USA-based ARCH Venture Partners revealed it has closed the ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies. 27 September 2024
USA-based biotech funder and incubator Flagship Pioneering yesterday unveiled Mirai Bio, a company pioneering the first open end-to-end platform for the biotech industry to enable the co-creation of fully optimized genetic medicines. 27 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024
Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024
Rare disease firm bluebird bio has announced a company-wide restructuring aimed at cutting costs by 20% and achieving quarterly cash flow break-even by the second half of 2025. 25 September 2024
Aptadir Therapeutics, a biotech company focused on RNA inhibitor-based therapies for cancer and genetic conditions, has launched with $1.6 million in pre-seed funding. 24 September 2024
Australian biotech company Telix Pharmaceuticals is to acquire USA-based RLS Radiopharmacies, expanding its manufacturing and distribution footprint in North America. 24 September 2024
British biotech Vicebio has secured $100 million in a series B funding round to accelerate the development of its next-generation vaccines against respiratory viruses. 23 September 2024
There was an emphasis on good times ahead in the communications put out by Merck KGaA as the German life sciences and pharma company welcomed analysts and investors to its 2017 Capital Markets Day on Thursday. 28 September 2017
Brandishing a 75 million-euro loan courtesy of the European Commission’s Investment Plan for Europe, German biotech firm Evotec has gone shopping. 28 September 2017
The share price of Ireland-incorporated drugmaker Allergan closed at $211.61 on Monday, up 3.4% for the day, after the company announced a $2 billion share buyback program and reiterated its pledge to pay down $3.75 billion of debt in 2018. 26 September 2017
There has been plenty of reaction on Monday to the news that the world’s biggest pharma company is effectively launching a start-up that it believes has a better chance of developing some of its drugs successfully. 25 September 2017
Polish biotech firm Selvita (PL: SLV) saw its share price rise 6.46% to 51.39 zlotys on Friday, when it published semi-annual financial results. 18 September 2017
French pharma major Sanofi and US biotech Regeneron Pharmaceuticals have announced that a pivotal Phase III study of dupilumab in a broad population of patients with uncontrolled, persistent asthma met its two primary endpoints. 11 September 2017
Eli Lilly has set out plants to streamline operations to more efficiently focus resources on developing new medicines and to improve its cost structure, as the US pharma major deals with pressure on the price of some of its biggest products. 8 September 2017
Shares in German life sciences company Merck KGaA had climbed by more than 3% to 95.10 euros ($113) by lunchtime on Tuesday after the firm announced it was preparing strategic options for its Consumer Health business. 5 September 2017
US gene therapy developer Abeona Therapeutics is set to start trading on Monday with a share price worth around $13.60, more than 50% higher than it was a week ago. 4 September 2017
Japanese conglomerate Fujifilm Holdings, best known for its photography and imaging operations, also has a sizeable business in healthcare, which it is hoping to expand. 31 August 2017
Nordic life sciences investment firm Karolinska Development is set to receive a significant chunk of shares in Xspray Pharma due to the product development company’s upcoming listing on Nasdaq First North. 25 August 2017
Scientists at the University of Massachusetts Medical School (UMMS) have spun out a gene therapy research program into a private company. 25 August 2017
The Medicines Manufacturing Industry Partnership has issued a report seeking government support for the building of four new ‘centres of excellence’ for medicines manufacturing across the UK. 23 August 2017
Merck Ventures, the venture capital arm of the German pharmaceutical group Merck KGaA has invested in the UK-based immuno-oncology company Macrophage Pharma, completing a previously announced series A financing round. 23 August 2017
Shares of Jordan-based Hikma Pharmaceuticals (LSE: HIK) dropped 11.8% to £11.75 in early London trading today, after it reported its interim results for the six months ended June 30, 2017 and expansion of a marketing deal with Japan’s largest drugmaker. 17 August 2017
Goldman Sachs cited Biogen’s experimental Alzheimer’s drug aducanumab as a major reason for its addition of the US biotech company to the investment bank’s Equity Conviction List. 17 August 2017
Australian biotech firm CSL Limited today announced a net profit after tax (NPAT) of $1,337 million (all figures US dollars) for the 12 months ended June 30, 2017. 16 August 2017
Beijing-based BeiGene has announced it will issue an additional 2,465,000 shares in a follow-on public offering that is expected to raise up to $175 million. 11 August 2017
Privately-held Apellis Pharmaceuticals, a biotech company based in Kentucky, USA, has closed a financing round aimed at raising $60 million to further clinical development. 11 August 2017
A pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news